Navigation Links
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
Date:2/26/2013

rom RMB280.7 million in the prior year period.
  • New subscriber sign-ups reached 56,169 and the accumulated subscriber base expanded to 295,923.
  • Gross profit increased by 44.2% to RMB313.4 million ($50.3 million) from RMB217.4 million in the prior year period.
  • Operating income increased by 58.6% to RMB158.6 million ($25.5 million) from RMB100.0 million in the prior year period.
  • Interest expense amounted to RMB48.0 million ($7.7 million), compared to RMB2.4 million in the prior year period.
  • Income before income tax was RMB124.6 million ($20.0 million), up 9.9%.
  • In the absence of the one-time tax benefit, net income attributable to the Company amounted to RMB89.4 million ($14.4 million), compared to RMB102.7 million in the prior year period.
  • Operating cash inflow for the first nine months of fiscal 2013 was RMB423.6 million ($68.0 million).

    • "The Company reached a major milestone in the third quarter of fiscal 2013 as we, for the first time, exceeded the 20,000 mark in quarterly new subscriber numbers, representing the highest increase in our new subscriber sign-ups in any single quarter, and generated record quarterly revenues," stated Ms. Ting Zheng, Chief Executive Officer of CCBC.  "Such achievements reflect our management team's years of dedication to setting out clear strategies and marketing approaches to optimize our marketing campaign, payment methods, and client base.  Our robust financial performance reflects the harvest of our continuous efforts to deepen penetration in our existing markets, which leads to ongoing expansion in our subscriber base, as well as increasingly high earnings and cash flows.  By continuously revamping our marketing approach, we have been able to achieve our short-to-medium term objectives in today's dynamic business environment."

     Summary – The Third Quarter and First Nine Months Ended December 31, 2011 and 2012Three Months
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
    2. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
    3. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    4. Lucintel’s Analysis of Growth Opportunities in China’s Composites Industry: Expect Market to Surpass $11 Billion in 2017
    5. China Cord Blood Corporation to Further Consolidate its Corporate Structure
    6. Biomaterials China News 1210 - Annual Subscription
    7. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
    8. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
    9. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
    10. China Biologic Products to Report Third Quarter 2012 Financial Results
    11. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/19/2013)... 2013   NineSigma , Inc., of ... its launch, NineSights.com is now the innovation ... the worldwide community of innovators. From technology ... experts, NineSights stands out for its large community of ... technical disciplines, all vetted by NineSigma. The community is ...
    (Date:6/19/2013)... , June 19, 2013 Biotechnology industry pioneer ... up with financial software provider BlackLine Systems  and ... SAP ) for a webinar next week entitled ... Solutions from BlackLine and SAP to Help Keep Its Account ... http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared at ...
    (Date:6/19/2013)... Canada (PRWEB) June 19, 2013 ... trial business can potentially be worth up to ... this opportunity, the Indian government is taking serious ... trials the process. , This presentation will examine:, ... trial regulations ,     Immediate and long term ...
    (Date:6/19/2013)... Blue Earth, MN (PRWEB) June 19, 2013 ... drugs of abuse tests, today announced that it has ... Canada to market and sell its DrugCheck® NxStep ... licensure allows use of the rapid screening device in ... NxStep Onsite Drug Screen Cup received Health Canada Class ...
    Breaking Biology Technology:NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
    ... first time, researchers have developed a 3D picture of ... of the human cellular machinery, enhancing our understanding of ... opening up new possibilities for stepping in to prevent ... many tactical manoeuvres employed by the virus. The ...
    ... (Nasdaq: BIOD ) today announced that Dr. ... present a corporate update at the 29th Annual JPMorgan ... a.m. Pacific Time (12:30 p.m. Eastern Time). The update ... formulations of its lead product, Linjeta™, including milestones and ...
    ... Biosciences, Inc. (Nasdaq: RDEA ) today announced ... of RDEA594 in combination with the current standard of ... accounts for greater than 90% of the unit sales ... only 30-40% of gout patients respond adequately to allopurinol ...
    Cached Biology Technology:Researchers visualize herpes virus' tactical maneuver 2Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 2Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 3Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 4Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 5Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 6Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients 7
    (Date:6/18/2013)... Scientists at the University of Calgary,s Faculty of Medicine ... the body from harmful bacteria. Platelets, a component of ... search for specific bacteria, and upon detection, seal it ... which were published in Nature Immunology this ... of immunity. , "The science community has known that ...
    (Date:6/18/2013)... At Brandeis University, sophisticated computational models and advances ... the complex interplay between genomic data, virus structure ... critical for replication. , "We ... will help researchers alter virus assembly, leaving viruses ... first author of the scientific paper describing the ...
    (Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
    Breaking Biology News(10 mins):Immunity mechanism discovered 2Computer modeling technique goes viral at Brandeis 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
    ... 4, 2010 -- Supercomputer simulations at the Department of Energy,s ... acids could have contributed to the origins of life. ... directs ORNL,s Center for Molecular Biophysics and holds a Governor,s ... probe an organic chemical reaction that may have been important ...
    ... USA (October 4, 2010) The Aeras Global TB ... grant from the United States Food and Drug Administration ... TB vaccine development. The FDA grant, which supports the ... United States, the United Kingdom and South Africa, will ...
    ... Major, PhD, assistant professor of cell and developmental biology, ... Health Director,s New Innovator Awards, one of the NIH,s ... fund his work to address a significant medical science ... contribute to specific cellular and disease processes such as ...
    Cached Biology News:Powerful supercomputer peers into the origin of life 2Aeras-led research consortium receives FDA support 2UNC scientist receives NIH director's New Innovator Award 2
    Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)...
    Bovine Pulmonary Artery Endothelial Cells (BPAEC) (>500,000 cells)...
    Bovine Aortic Smooth Muscle Cells (BAOSMC) (>500,000 cells)...
    Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
    Biology Products: